3Ksuajima J M, Ishida R, Uchida H. Phototoxicity gatifloxacin. a new quinolone, and its related drugs in guinea pigs[J]. Drugs, 1999,58(2):397. 被引量：1
4Wakabayshi E, Mitsuhashi S. In vitro antibacterial activity of AM-1155, novel 6-fluoro-8-methoxy quinolone[J].Antimicrob Agents Chemother.1994:38(3):594-601. 被引量：1
5Edind LM,Jacobs MR,Appelbaum PC.Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms[J]. Antimicrob Agents Chemother,1998,42(9):2459-2462. 被引量：1
6Miyashita N , Niki Y, Kishimoto T, et al. In vitro and in vivo activities of Am-1155 ,a new fluoroquinolone, against Chlamydia spp[J]. Antimicrob Agents Chemother,1997,41(6):1331-1334. 被引量：1
7Nakashima M, Uematsu T , Kosuge K , et al.Single- and mutiple- dose pharmacokineties of AM-1155 ,a new 6-fluoro 8-8methoxy quinolone ,in humans[J]. Antimicrob Agents Chemother,1995,39:2635-2640. 被引量：1
8Kawada Y,kanimoto Y,Takahashi,et al. Pharmacokinetics of gatifloxacin(AM-1155) in patients with impaired rental funtion[J]. Anti-Infect drug Chemother,1998,16(suppl 1)L69. 被引量：1
9Grasela D, Christofalo B, Lacreta F, et al. Safety and pharmacokinetics of a single oral of gatifloxacin in patients with moderate to severe hepatic impairment[J].Pharmacotherapy, 2000,20:87-94. 被引量：1
10Dresser LD,Niederman MS,Paladino JA. Cost-effectiveness of gatifloxacin vs ceftraxone with a macrolide for the treatment of community-acquired pneumonia[J]. Chest,2001,119:1439-1448. 被引量：1
